Asia-Pacific Cancer Immunotherapy Market by Application - (Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others), by Product Type – (Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, Interferons, Interleukins, BCG and others) by Mode of Administration – (Intravenous, Oral, Topical, Intravesical), by End users (Hospitals, Clinics) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Cancer Immunotherapy Market by Application - (Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others), by Product Type – (Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, Interferons, Interleukins, BCG and others) by Mode of Administration – (Intravenous, Oral, Topical, Intravesical), by End users (Hospitals, Clinics) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1415 | Pages: 132 | November 2016 | Region: Asia Pacific


The Asia-Pacific Cancer Immunotherapy Market was worth $ 10.54 Billion in 2016 and estimated to reach $ 19.59 Billion by the end of 2021 with a growing potential of 13.20 %.

Immunotherapy is a type of treatment option that helps your immune system fight against cancer. Normally, the immune system helps the body fight against infections and other diseases. It is made up of organs, white blood cells and tissues of the lymph system. Immunotherapy is a type of biological therapy that is a type of treatment which uses substances made from living organisms to treat cancer.

The key drivers of the Asia-Pacific Cancer immunotherapy market are increasing occurrence of cancer, Changing life style, Smoking and excessive alcoholic intake, high efficacy of immunotherapy compared to other treatments, less side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer. Various cancers like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology are the major factors restraining the growth of the market.

Asia-Pacific Cancer immunotherapy market is segmented based on Application into Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others. Based on product type, the market is segmented into Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, BCG and others. Based on Mode of administration, the market is segmented into Intravenous, Oral, Topical, and Intravesical. Based on end users, the market is categorized into hospitals, clinics. Based on Geography, the Asia-Pacific Cancer immunotherapy market is analysed under various regions namely China, India, Japan, South Korea and Australia.

Key players in the Asia-Pacific cancer immunotherapy Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp, Immunomedics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Breast       

                                5.1.3 Lung          

                                5.1.4 Melanoma              

                                5.1.5 Colorectal

                                5.1.6 Head & Neck          

                                5.1.7 Prostate   

                                5.1.8 Others      

                                5.1.9 Y-o-Y Growth Analysis, By Application         

                                5.1.10 Market Attractiveness Analysis, By Application     

                                5.1.11 Market Share Analysis, By Application      

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Monoclonal Antibodies     

                                5.2.3 Checkpoint inhibitors/immune modulators              

                                5.2.4 Therapeutic cancer vaccines            

                                5.2.5 Oncolytic virus immunotherapy     

                                5.2.6 Cytokines

                                5.2.7 Adoptive T cell transfer     

                                5.2.8 Adjuvant Immunotherapy

                                5.2.9 Interferons             

                                5.2.10 Interleukins         

                                5.2.11 BCG         

                                5.2.12 Others   

                                5.2.13 Y-o-Y Growth Analysis, By Product Type   

                                5.2.14 Market Attractiveness Analysis, By Product Type

                                5.2.15 Market Share Analysis, By Product Type  

                5.3 Mode of Administration                        

                                5.3.1 Introduction           

                                5.3.2 Intravenous           

                                5.3.3 Oral            

                                5.3.4 Topical      

                                5.3.5 Intra Vesical           

                                5.3.6 Y-o-Y Growth Analysis, By Mode of Administration

                                5.3.7 Market Attractiveness Analysis, By Mode of Administration              

                                5.3.8 Market Share Analysis, By Mode of Administration

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Y-o-Y Growth Analysis, By End users            

                                5.3.5 Market Attractiveness Analysis, By End users           

                                5.3.6 Market Share Analysis, By End users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Mode of Administration

                                                6.1.3.5 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Mode of Administration

                                                6.1.4.5 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Mode of Administration

                                                6.1.5.6 By End users

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche Ltd                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen                         

                8.3 Viralytics                      

                8.4 Novartis Pharmaceuticals Corporation                            

                8.5 Pfizer                            

                8.6 GlaxoSmithKline Pharmaceuticals Limited                     

                8.7 AstraZeneca plc                        

                8.8 Medivation                

                8.9 Advaxis                        

                8.10 Bristol-Myers Squibb                           

                8.11 Merck & Co. and Celgene Corp                        

                8.12 Immunomedics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Breast Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Lung Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Melanoma Market By Region, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Colorectal Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Head & Neck Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Prostate Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Checkpoint inhibitors/immune modulators Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Therapeutic cancer vaccines Market By Region, From 2016-2021 ( USD Billion )
  12. Asia-Pacific Oncolytic virus immunotherapy Market By Region, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Cytokines Market By Region, From 2016-2021 ( USD Billion )
  14. Asia-Pacific Adoptive T cell Transfer Market By Region, From 2016-2021 ( USD Billion )
  15. Asia-Pacific Adjuvant immunotherapy Market By Region, From 2016-2021 ( USD Billion )
  16. Asia-Pacific Interferons Market By Region, From 2016-2021 ( USD Billion )
  17. Asia-Pacific Interleukins Market By Region, From 2016-2021 ( USD Billion )
  18. Asia-Pacific BCG Market By Region, From 2016-2021 ( USD Billion )
  19. Asia-Pacific Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  20. Asia-Pacific Intravenous Market By Region, From 2016-2021 ( USD Billion )
  21. Asia-Pacific Oral Market By Region, From 2016-2021 ( USD Billion )
  22. Asia-Pacific Topical Market By Region, From 2016-2021 ( USD Billion )
  23. Asia-Pacific Intravesical Market By Region, From 2016-2021 ( USD Billion )
  24. Asia-Pacific Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  25. Asia-Pacific hospitals Market By Region, From 2016-2021 ( USD Billion )
  26. Asia-Pacific Clinics Market By Region, From 2016-2021 ( USD Billion )
  27. Japan Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  28. Japan Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  29. Japan Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  30. Japan Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  31. China Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  32. China Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  33. China Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  34. China Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  35. India Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  36. India Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  37. India Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  38. India Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  39. South korea Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  40. South korea Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  41. South korea Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  42. South korea Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  43. Australia Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  44. Australia Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  45. Australia Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  46. Australia Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.